[Effects of serum components of patients with liver diseases on hepatocyte cytotoxicity and plasminogen activator production of activated macrophages].
D000818:Animals; D003602:Cytotoxicity, Immunologic; D006168:Guinea Pigs; D006801:Humans; D008099:Liver / Q000276:immunology*; D008107:Liver Diseases / Q000276:immunology*; D008222:Lymphokines / Q000097:blood*; D016215:Macrophage-Activating Factors; D008264:Macrophages / Q000201:enzymology / Q000276:immunology*; D010960:Plasminogen Activators / Q000378:metabolism*
D008222:Lymphokines; D016215:Macrophage-Activating Factors; D010960:Plasminogen Activators